Dark Forest Capital Management LP Glaukos Corp Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $2,904 - $3,626	62 New	62 $3,000
Q2 2022 Aug 15, 2022	SELL	$34.86 - $63.77 $453 - $829	-13 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$44.33 - $57.82 $1,329 - $1,734	-30 Reduced 69.77%	13 $1,000
Q4 2021 Feb 11, 2022	BUY	$40.27 - $56.99 $1,731 - $2,450	43 New	43 $2,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.